Follow the evidence.
Proposed monitoring of trial progress, endpoints and reported results, with links to underlying sources and clear distinctions between expected and confirmed events.
Clinical trial intelligenceInstitutional life sciences intelligence
The Intelligence Behind Life Sciences Markets.
A specialist intelligence platform in development for institutional healthcare equity trading and research. Connecting clinical developments, regulatory catalysts and company pipelines.
Early development · Shaped by institutional workflowsVEXISGRIDConcept preview
CatalystsCompaniesPipelinesWatchlists
Illustrative workspace / life sciencesGlobal view
What matters next.
Northbridge Bio · Phase III readoutOncology · Primary endpoint · Timing estimated
ClinicalMeridian Therapeutics · Regulatory reviewRare disease · Decision window · Source pending
RegulatoryArcwell Medical · Study updateMedical technology · Follow-up results
ClinicalPROPOSED WORKFLOWMonitor → Verify
CONTEXT THAT MATTERSSource + Timing
Conceptual interface only. All companies and events shown are fictional. No live data, functioning terminal or trading capability is represented.
Sector focus Biotechnology / Pharmaceuticals / Medical TechnologyIntended coverage Americas / EMEA / APAC
The proposed platform
Clinical detail.
Market context.
Life sciences equities sit at the intersection of complex evidence and time-sensitive events. Our ambition is to bring those connections into a focused, traceable workspace that complements institutional research and trading tools.
Know what is approaching.
A planned catalyst view connecting regulatory milestones to relevant companies and assets. Dates, jurisdictions and uncertainty would remain visible.
Regulatory catalyst trackingConnect the wider picture.
Planned company and pipeline context to help professional users navigate assets, indications and forthcoming milestones alongside their existing analysis.
Company & pipeline insightBuilt around professional questions
For people who work
in healthcare equities.
We are seeking conversations with institutional market participants to understand where specialist intelligence could improve daily workflows. These audiences are our intended users, not existing customers.
Equity trading desks
Institutional brokerage, healthcare traders and sales trading teams.
Specialist investors
Healthcare-focused hedge funds and institutional asset managers.
Equity research
Biotechnology, pharmaceutical and medical technology analysts.
Relevant bank teams
Healthcare research and equity markets divisions with aligned workflows.
Help shape what comes next
Specialist insight.
Shared ambition.
We welcome exploratory discussions with prospective institutional users, commercial cofounders and technology or data partners.